Clinical Trial Update: Study of Rapamycin Plus Ketoconazole in Advanced Cancers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of rapamycin and ketoconazole in patients with advanced cancer has completed, sponsored by the University of Chicago.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Rapamycin (sirolimus)

Snippet

Sponsor: University of Chicago | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED